Comparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma-Reference-Cited by-同舟云学术

Comparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma

Published:2014-06-27 Issue:2 Volume:56 Page:377-382
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Bednaruk-Młyński Ewa,Pieńkowska Joanna,Skórzak Adam,Małkowski Bogdan,Kulikowski Waldemar,Subocz Edyta,Dzietczenia Justyna,Zalewska Marta,Leśniewski-Kmak Krzysztof,Zaucha Renata,Wróbel Tomasz,Zaucha Jan M.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.919635

Reference28 articles.

1. Imaging in staging of malignant lymphoma: a systematic review

2. 18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients

3. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease

4. A metaanalysis of18F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hodgkin's Lymphoma In Low-Income Countries: Experience Of Togo;Journal of Hematology and Oncology Research;2024-03-04

2. Evolution of Radiation Fields from Involved Field to Involved Site—A Summary of the Current Guidelines by the International Lymphoma Radiation Oncology Group;Lymphatics;2023-11-08

3. Modern PET-Guided Radiotherapy Planning and Treatment for Malignant Lymphoma;Seminars in Nuclear Medicine;2023-05

4. Evaluation of radiation doses of the 18FDG PET/CT hybrid imaging in adult and paediatric oncologic patients;Radiation Physics and Chemistry;2023-02

5. High-risk relapsed or refractory classic Hodgkin lymphoma cure: how to make the impossible possible;The Lancet Haematology;2023-01